Drug intelligence / Profile preview

PY2

Development stage
Preclinical
Lead developer
University of Urbino
Modality
Small Molecules
01

Overview

PY2 is a synthetic amino-pyrimidine analog of curcumin designed to address the inherent limitations of natural curcumin, such as its rapid degradation and poor bioavailability. By replacing the unstable 1,3-diketone moiety of curcumin with an amino-pyrimidine ring, PY2 achieves significantly enhanced chemical stability in physiological media. Preclinical evaluations have demonstrated that PY2 possesses potent anti-proliferative activity against several cancer cell lines, including prostate cancer (PC3 and LNCaP) and colorectal cancer (HCT116 and HT29). Its mechanism of action is believed to be pleiotropic, similar to curcumin, involving the modulation of multiple signaling pathways related to cell survival and apoptosis, although it shows improved cytotoxicity in specific models like PC3 cells.

Other names
4,6-bis((E)-4-hydroxy-3-methoxystyryl)pyrimidin-2-aminePyrimidine-curcumin analog 2

Beyond the preview

Go deeper on PY2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PY2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call